See more : Rithm Capital Corp. (RITM) Income Statement Analysis – Financial Results
Complete financial analysis of Tellgen Corporation (300642.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tellgen Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
- Cofix Group Ltd (CFX.TA) Income Statement Analysis – Financial Results
- CPI Computer Peripherals International (CPI.AT) Income Statement Analysis – Financial Results
- Alliance Witan Ord (ALW.L) Income Statement Analysis – Financial Results
- Founder SPAC (FOUNU) Income Statement Analysis – Financial Results
- Carbon Minerals Limited (CRM.AX) Income Statement Analysis – Financial Results
Tellgen Corporation (300642.SZ)
About Tellgen Corporation
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 542.81M | 715.97M | 654.59M | 489.58M | 441.45M | 364.85M | 302.89M | 231.22M | 169.38M | 118.20M | 76.83M | 48.71M |
| Cost of Revenue | 188.58M | 307.57M | 217.00M | 164.53M | 94.60M | 78.69M | 58.88M | 44.65M | 31.46M | 21.90M | 14.63M | 10.31M |
| Gross Profit | 354.23M | 408.40M | 437.59M | 325.05M | 346.85M | 286.15M | 244.01M | 186.57M | 137.92M | 96.30M | 62.19M | 38.40M |
| Gross Profit Ratio | 65.26% | 57.04% | 66.85% | 66.39% | 78.57% | 78.43% | 80.56% | 80.69% | 81.43% | 81.47% | 80.95% | 78.84% |
| Research & Development | 77.72M | 79.33M | 72.71M | 61.47M | 51.99M | 40.00M | 29.65M | 21.77M | 18.13M | 18.63M | 9.95M | 0.00 |
| General & Administrative | 8.60M | 9.15M | 9.86M | 7.17M | 8.64M | 14.03M | 1.07M | 5.25M | 2.85M | 3.91M | 17.83M | 11.78M |
| Selling & Marketing | 175.52M | 194.58M | 181.39M | 124.22M | 111.37M | 83.27M | 66.67M | 45.53M | 37.16M | 26.66M | 19.62M | 13.44M |
| SG&A | 184.12M | 203.73M | 191.24M | 131.39M | 120.01M | 97.29M | 67.73M | 50.78M | 40.01M | 30.57M | 37.45M | 25.22M |
| Other Expenses | 0.00 | 17.49M | 27.36M | -354.87K | -671.28K | -74.46K | -27.22K | 7.16M | 4.57M | 1.87M | 2.00M | 2.39M |
| Operating Expenses | 265.87M | 308.12M | 291.15M | 196.05M | 177.91M | 133.84M | 103.23M | 80.62M | 65.27M | 54.39M | 38.17M | 25.56M |
| Cost & Expenses | 454.45M | 615.69M | 508.15M | 360.58M | 272.51M | 212.54M | 162.11M | 125.28M | 96.73M | 76.29M | 52.80M | 35.86M |
| Interest Income | 5.92M | 5.53M | 5.46M | 1.29M | 6.46M | 5.01M | 7.00M | 319.48K | 257.40K | 208.64K | 260.85K | 0.00 |
| Interest Expense | 726.15K | 741.11K | 1.11M | 135.28K | 18.25K | 662.16 | 354.66K | 595.49K | 818.95K | 974.27K | 0.00 | 0.00 |
| Depreciation & Amortization | 85.29M | 83.46M | 75.02M | 57.52M | 45.19M | 34.56M | 26.21M | 19.63M | 12.41M | 9.29M | 5.62M | 3.73M |
| EBITDA | 168.68M | 212.17M | 251.67M | 191.23M | 227.68M | 200.41M | 173.84M | 131.19M | 91.38M | 52.57M | 29.65M | 16.58M |
| EBITDA Ratio | 31.08% | 31.93% | 39.81% | 39.25% | 50.64% | 54.49% | 57.21% | 56.94% | 53.68% | 45.43% | 38.96% | 34.46% |
| Operating Income | 88.36M | 131.43M | 180.54M | 132.25M | 181.81M | 165.42M | 147.21M | 105.90M | 72.44M | 40.63M | 24.03M | 13.48M |
| Operating Income Ratio | 16.28% | 18.36% | 27.58% | 27.01% | 41.19% | 45.34% | 48.60% | 45.80% | 42.77% | 34.37% | 31.27% | 27.67% |
| Total Other Income/Expenses | -878.07K | -769.38K | -2.36M | -1.87M | -671.27K | -74.46K | -27.22K | 7.11M | 4.55M | 1.68M | 1.95M | 2.39M |
| Income Before Tax | 87.48M | 130.66M | 178.18M | 130.38M | 181.14M | 165.35M | 147.18M | 113.01M | 76.98M | 42.30M | 25.97M | 15.87M |
| Income Before Tax Ratio | 16.12% | 18.25% | 27.22% | 26.63% | 41.03% | 45.32% | 48.59% | 48.87% | 45.45% | 35.79% | 33.81% | 32.57% |
| Income Tax Expense | 2.79M | 6.92M | 17.12M | 9.82M | 24.13M | 23.66M | 20.37M | 15.24M | 11.21M | 6.30M | 3.40M | 2.25M |
| Net Income | 89.40M | 124.76M | 161.08M | 120.55M | 157.02M | 141.69M | 126.81M | 97.77M | 65.78M | 36.00M | 22.58M | 13.62M |
| Net Income Ratio | 16.47% | 17.42% | 24.61% | 24.62% | 35.57% | 38.84% | 41.87% | 42.28% | 38.83% | 30.46% | 29.39% | 27.96% |
| EPS | 0.55 | 0.77 | 0.99 | 0.74 | 0.97 | 0.87 | 0.85 | 0.80 | 0.54 | 0.30 | 0.19 | 0.00 |
| EPS Diluted | 0.55 | 0.77 | 0.98 | 0.74 | 0.97 | 0.87 | 0.85 | 0.80 | 0.54 | 0.30 | 0.19 | 0.00 |
| Weighted Avg Shares Out | 163.15M | 162.40M | 163.20M | 163.33M | 162.45M | 162.24M | 148.51M | 121.64M | 121.65M | 121.51M | 121.50M | 0.00 |
| Weighted Avg Shares Out (Dil) | 163.15M | 162.56M | 164.37M | 163.33M | 162.45M | 162.34M | 148.51M | 121.64M | 121.65M | 121.51M | 121.50M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports